|
ABORTION | CLINIC
VIOLENCE | CONTRACEPTION
| GLOBAL | MEDICAL ABORTION |
REPRO HEALTH
Medical Abortion
On September 28, 2000, the FDA approved Mifepristone for
use in the United States after a 12-year campaign waged by the Feminist
Majority Foundation. Already, anti-choice activists are mobilizing
to prevent women from accessing Mifepristone.
In states like Florida, for example, both public and private universities
say they will not make Mifepristone available at campus health clinics.
Increasing numbers of universities across the country are following
suit. The FDA requires that any facility prescribing mifepristone
be able to make arrangements for surgical back-up referral in the
few instances when the drug fails to complete an abortion. Many
college health centers meet those requirements but are nonetheless
rejecting Mifepristone because it offers a form of abortion.
Mifepristone also has implications for the treatment of fibroid
tumors, ovarian cancer, endemetriosis, meningioma, and some types
of breast cancer.
Feminist
Majority Foundation: Campaign for RU 486 and Contraceptive Research
Statements and Press
Releases on Mifepristone (RU 486)
Feminist Majority
Report Articles on Mifepristone (RU 486)
Feminist News Stories
on Mifepristone (RU 486)
The Abortion Rights Activist
This site provides information about abortions, referrals, RU 486,
methotrexate and misoprostol, as well as emergency contraception.
Danco Laboratories
Danco Laboratories markets Mifeprex (the trade name for mifepristone)
in the United States. Their site contains information on mifepristone
and its uses, as well as instructions
on how to get Mifeprex.
Early Options
This site is administered by the National Abortion Federation (NAF)
in an effort to "educate and instruct health care professionals...in
the safe and effective administration of mifepristone/misoprostol
for early medical abortion." NAF is accredited by the ACCME
and offers health care professionals the opportunity to obtain CME
credits specifically on medical abortion. The site also contains
information for women considering medical abortion.
NARAL
The National Abortion Rights Action League's site provides information
on the history of mifepristone and its impact on abortion politics
and research. Also included is a time
line that follows the fight to bring mifepristone to the US,1980-1996.
National Abortion
Federation (NAF)
Read NAF's Fact Sheet on medical abortion.
NOW
Statement Concerning Mifepristone
National Organization for Women director of government relations
and public policy Jan Erikson urged the FDA's approval of mifepristone
at a July 19, 1996 hearing.
Population
Council
The Population Council's website contains general
information on medical abortion as well as the results of their
clinical trials of mifepristone. Particular sections to visit in
this site include:
"Medical
Abortion: Safe, Effective, and Acceptable to Women in Developing
Countries"
"Evidence
Accrues on Safety, Efficacy, and Acceptability of Early Medical
Abortion"
"Population
Council Welcomes FDA Approval of MifeprexT (mifepristone)"
ABORTION | CLINIC
VIOLENCE | CONTRACEPTION
| GLOBAL | MEDICAL ABORTION
| REPRO HEALTH
|
